Circulating profiling reveals the effect of a polyunsaturated fatty acid-enriched diet on common microRNAs

Journal of Nutritional Biochemistry

Volumn 26, Issue 10, 2015, Pages 1095-1101

  Ortega, Francisco J ^a   Cardona Alvarado, Mónica I ^b   Mercader, Josep M ^c   Moreno Navarrete, José M ^a   Moreno, María ^a   Sabater, Mònica ^a   Fuentes Batllevell, Núria ^a   Ramírez Chávez, Enrique ^d   Ricart, Wifredo ^a   Molina Torres, Jorge ^d   Pérez Luque, Elva L ^b   Fernández Real, José M ^a  

^a GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^b UNIVERSITY OF GUANAJUATO   (Mexico)

^c BARCELONA SUPERCOMPUTING CENTER   (Spain)

^d DEPARTAMENTO DE INGENIERÍA GENÉTICA   (Mexico)

Author keywords

Circulating microRNAs; Diet; LDL cholesterol; Omega 3; Omega 6; Polyunsaturated fatty acids

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; MICRORNA; MICRORNA 106A; MICRORNA 125A 5P; MICRORNA 130B; MICRORNA 18A; MICRORNA 192; MICRORNA 19B; MICRORNA 221; MICRORNA 328; MICRORNA 330 3P; MICRORNA 486 5P; MICRORNA 769 5P; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; EDIBLE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; UNSATURATED FATTY ACID;

ADULT; ALMOND; ARTICLE; BLOOD LEVEL; CORRELATION ANALYSIS; DIET; FEMALE; GAS LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; OUTCOME ASSESSMENT; WALNUT; BLOOD; BODY MASS; CHEMISTRY; MEXICO; MIDDLE AGED; NUT; SEDENTARY LIFESTYLE;

ADIPONECTIN; ADULT; BIOMARKERS; BODY MASS INDEX; DIET; DIETARY FATS, UNSATURATED; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MEXICO; MICRORNAS; MIDDLE AGED; NUTS; SEDENTARY LIFESTYLE; TRIGLYCERIDES;

EID: 84942550179     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.05.001     Document Type: Article

References (42)

1. Zimmermann M.B., Aeberli I. Dietary determinants of subclinical inflammation, dyslipidemia and components of the metabolic syndrome in overweight children: a review. Int J Obes (Lond) 2008, 32(Suppl. 6):S11-S18.
2. Blackburn P., Despres J.P., Lamarche B., Tremblay A., Bergeron J., Lemieux I., et al. Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) 2006, 14:1747-1754.
3. Berryman C.E., Preston A.G., Karmally W., Deckelbaum R.J., Kris-Etherton P.M. Effects of almond consumption on the reduction of LDL-cholesterol: a discussion of potential mechanisms and future research directions. Nutr Rev 2011, 69:171-185.
4. Kendall C.W., Esfahani A., Truan J., Srichaikul K., Jenkins D.J. Health benefits of nuts in prevention and management of diabetes. Asia Pac J Clin Nutr 2010, 19:110-116.
5. Sabate J., Wien M. Nuts, blood lipids and cardiovascular disease. Asia Pac J Clin Nutr 2010, 19:131-136.
6. Vinson J.A., Cai Y. Nuts, especially walnuts, have both antioxidant quantity and efficacy and exhibit significant potential health benefits. Food Funct 2012, 3:134-140.
7. Spady D.K. Regulatory effects of individual n-6 and n-3 polyunsaturated fatty acids on LDL transport in the rat. J Lipid Res 1993, 34:1337-1346.
8. Hassanali Z., Ametaj B.N., Field C.J., Proctor S.D., Vine D.F. Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat. Diabetes Obes Metab 2010, 12:139-147.
9. Calder P.C. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 2008, 52:885-897.
10. Flachs P., Rossmeisl M., Bryhn M., Kopecky J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond) 2009, 116:1-16.
11. Fernandez-Real J.M., Vendrell J., Ricart W. Circulating adiponectin and plasma fatty acid profile. Clin Chem 2005, 51:603-609.
12. Gorjao R., Verlengia R., Lima T.M., Soriano F.G., Boaventura M.F., Kanunfre C.C., et al. Effect of docosahexaenoic acid-rich fish oil supplementation on human leukocyte function. Clin Nutr 2006, 25:923-938.
13. Kopecky J., Rossmeisl M., Flachs P., Kuda O., Brauner P., Jilkova Z., et al. n-3 PUFA: bioavailability and modulation of adipose tissue function. Proc Nutr Soc 2009, 68:361-369.
14. Rossi A.S., Lombardo Y.B., Lacorte J.M., Chicco A.G., Rouault C., Slama G., et al. Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. Am J Physiol Regul Integr Comp Physiol 2005, 289:R486-R494.
15. Fernandez-Real J.M., Broch M., Vendrell J., Ricart W. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 2003, 26:1362-1368.
16. Senthil Kumar S.P., Shen M., Spicer E.G., Goudjo-Ako A.J., Stumph J.D., Zhang J., et al. Distinct metabolic effects following short-term exposure of different high-fat diets in male and female mice. Endocr J 2014, 61:457-470.
17. Delarue J., LeFoll C., Corporeau C., Lucas D. N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?. Reprod Nutr Dev 2004, 44:289-299.
18. Zampetaki A., Willeit P., Drozdov I., Kiechl S., Mayr M. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res 2012, 93:555-562.
19. Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011, 13:423-433.
20. Turchinovich A., Weiz L., Langheinz A., Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011, 39:7223-7233.
21. Zampetaki A., Kiechl S., Drozdov I., Willeit P., Mayr U., Prokopi M., et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 2010, 107:810-817.
22. Guay C., Roggli E., Nesca V., Jacovetti C., Regazzi R. Diabetes mellitus, a microRNA-related disease?. Transl Res 2011, 157:253-264.
23. Ortega F.J., Mercader J.M., Catalan V., Moreno-Navarrete J.M., Pueyo N., Sabater M., et al. Targeting the circulating microRNA signature of obesity. Clin Chem 2013, 59:781-792.
24. Prats-Puig A., Ortega F.J., Mercader J.M., Moreno-Navarrete J.M., Moreno M., Bonet N., et al. Changes in circulating microRNAs are associated with childhood obesity. J Clin Endocrinol Metab 2013, 98:E1655-E1660.
25. Ortega F.J., Mercader J.M., Moreno-Navarrete J.M., Rovira O., Guerra E., Esteve E., et al. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care 2014, 37:1375-1383.
26. Nishida C., Uauy R., Kumanyika S., Shetty P. The joint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr 2004, 7:245-250.
27. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
28. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3. [RESEARCH0034].
29. Papadopoulos G.L., Alexiou P., Maragkakis M., Reczko M., Hatzigeorgiou A.G. DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics 2009, 25:1991-1993.
30. Vergoulis T., Vlachos I.S., Alexiou P., Georgakilas G., Maragkakis M., Reczko M., et al. TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res 2012, 40:D222-D229.
31. Catalan V., Gomez-Ambrosi J., Rodriguez A., Ramirez B., Rotellar F., Valenti V., et al. Increased circulating and visceral adipose tissue expression levels of YKL-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass. J Clin Endocrinol Metab 2011, 96:200-209.
32. Nielsen S., Akerstrom T., Rinnov A., Yfanti C., Scheele C., Pedersen B.K., et al. The miRNA plasma signature in response to acute aerobic exercise and endurance training. PLoS One 2014, 9:e87308.
33. Zhang X., Shao S., Geng H., Yu Y., Wang C., Liu Z., et al. Expression profiles of six circulating microRNAs critical to atherosclerosis in patients with subclinical hypothyroidism: a clinical study. J Clin Endocrinol Metab 2014, 99:E766-E774.
34. Jenkins D.J., Kendall C.W., Marchie A., Parker T.L., Connelly P.W., Qian W., et al. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation 2002, 106:1327-1332.
35. Tapsell L.C., Gillen L.J., Patch C.S., Batterham M., Owen A., Bare M., et al. Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 2004, 27:2777-2783.
36. Katz D.L., Davidhi A., Ma Y., Kavak Y., Bifulco L., Njike V.Y. Effects of walnuts on endothelial function in overweight adults with visceral obesity: a randomized, controlled, crossover trial. J Am Coll Nutr 2012, 31:415-423.
37. Jenkins D.J., Kendall C.W., Marchie A., Faulkner D.A., Wong J.M., de Souza R., et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 2003, 290:502-510.
38. Banel D.K., Hu F.B. Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic review. Am J Clin Nutr 2009, 90:56-63.
39. Kalgaonkar S., Almario R.U., Gurusinghe D., Garamendi E.M., Buchan W., Kim K., et al. Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS. Eur J Clin Nutr 2011, 65:386-393.
40. Lozano A., Perez-Martinez P., Marin C., Tinahones F.J., Delgado-Lista J., Cruz-Teno C., et al. An acute intake of a walnut-enriched meal improves postprandial adiponectin response in healthy young adults. Nutr Res 2013, 33:1012-1018.
41. Ros E. Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr 2009, 89:1649S-1656S.
42. Estruch R., Martinez-Gonzalez M.A., Corella D., Salas-Salvado J., Ruiz-Gutierrez V., Covas M.I., et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006, 145:1-11.